» Articles » PMID: 17982038

Memory CD8+ T Cells Require CD28 Costimulation

Overview
Journal J Immunol
Date 2007 Nov 6
PMID 17982038
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

CD8(+) T cells are a critical component of the adaptive immune response against infections and tumors. A current paradigm in immunology is that naive CD8(+) T cells require CD28 costimulation, whereas memory CD8(+) T cells do not. We show here, however, that during viral infections of mice, costimulation is required in vivo for the reactivation of memory CD8(+) T cells. In the absence of CD28 costimulation, secondary CD8(+) T cell responses are greatly reduced and this impairs viral clearance. The failure of CD8(+) T cells to expand in the absence of CD28 costimulation is CD4(+) T cell help independent and is accompanied by a failure to down-regulate Bcl-2 and by cell cycle arrest. This requirement for CD28 costimulation was shown in both influenza A and HSV infections. Thus, contrary to current dogma, memory CD8(+) T cells require CD28 costimulation to generate maximal secondary responses against pathogens. Importantly, this CD28 requirement was shown in the context of real infections were multiple other cytokines and costimulators may be up-regulated. Our findings have important implications for pathogens, such as HIV and measles virus, and tumors that evade the immune response by failing to provide CD28 costimulation. These findings also raise questions about the efficacy of CD8(+) T cell-based vaccines against such pathogens and tumors.

Citing Articles

Decoding senescence of aging single cells at the nexus of biomaterials, microfluidics, and spatial omics.

Venkataraman A, Kordic I, Li J, Zhang N, Bharadwaj N, Fang Z NPJ Aging. 2024; 10(1):57.

PMID: 39592596 PMC: 11599402. DOI: 10.1038/s41514-024-00178-w.


Artificial antigen-presenting cell system reveals CD28's role in modulating T cell functions during human immunodeficiency virus infection.

Kabakibo T, Arnold E, Padhan K, Lemieux A, Ortega-Delgado G, Routy J iScience. 2024; 27(10):110947.

PMID: 39381752 PMC: 11460474. DOI: 10.1016/j.isci.2024.110947.


Validation of a PD-1/CD28 chimeric switch receptor to augment CAR-T function in dogs with spontaneous B cell lymphoma.

Yoshimoto S, Kudo A, Rotolo A, Foos K, Olenick L, Takagi S iScience. 2024; 27(9):110863.

PMID: 39314237 PMC: 11418608. DOI: 10.1016/j.isci.2024.110863.


Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid Tumors.

Lin H, Uricoli B, Freeman R, Hossian A, He Z, Anderson J Adv Healthc Mater. 2024; 13(14):e2302425.

PMID: 38245855 PMC: 11144092. DOI: 10.1002/adhm.202302425.


The lncRNA inhibits miR-15/16 to enhance cytotoxic T cell activation and memory cell formation.

Wheeler B, Gagnon J, Zhu W, Munoz-Sandoval P, Wong S, Simeonov D Elife. 2023; 12.

PMID: 38127070 PMC: 10735224. DOI: 10.7554/eLife.87900.